NCT00603187View on ClinicalTrials.gov

ACY-7 Oral Administration of Acyline

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

Acyline

20 mg GIPET enhanced oral dose, daily for 7-days

Trial Locations (1)

98195

University of Washington, Seattle

Sponsors
All Listed Sponsors
collaborator

Merrion Pharmaceuticals, LLC

INDUSTRY

lead

University of Washington

OTHER